View Older Stories View More Recent Stories

Jun 17, 2026 05:26PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Jun 17, 2026 05:26PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Opportunity Fund I, L.P.
Jun 10, 2026 08:02AM Junevity Partners with Sunrise BioVentures as Advisors to Accelerate siRNA Therapeutic Development
Jun 10, 2026 07:00AM Ethyreal Bio Emerges from Stealth with $101 Million in Financing to Advance ETHY-001, a Potentially Best-in-Class Anti-TSHR Antibody for Thyroid Eye Disease and Graves’ Disease
Jun 8, 2026 04:30PM Form 3 Q32 Bio Inc. For: May 26 Filed by: Atlas Venture Associates Opportunity III, LLC
Jun 8, 2026 08:31AM Lifordi Immunotherapeutics Presents Phase 1 Clinical Data for LFD-200, a Subcutaneous Glucocorticoid Antibody Drug Conjugate, at EULAR 2026
May 28, 2026 04:29PM Form SCHEDULE 13D/A Q32 Bio Inc. Filed by: Atlas Venture Fund X, L.P.
May 27, 2026 08:41AM Q32 Bio shares up 26% on $55 million financing round
May 27, 2026 08:00AM Q32 Bio raises $55 million in private placement financing
May 27, 2026 08:00AM Q32 Bio Announces $55 Million Private Placement Financing
May 14, 2026 04:30PM Form 13F-HR Atlas Venture Life Scien For: Mar 31
May 14, 2026 04:25PM Form SCHEDULE 13G/A Generation Bio Co. Filed by: Atlas Venture Fund X, L.P.
May 14, 2026 04:21PM Form SCHEDULE 13G/A Day One Biopharmaceutica Filed by: Atlas Venture Fund XI, L.P.
May 6, 2026 04:44PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
May 6, 2026 04:43PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
May 6, 2026 04:43PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
May 6, 2026 04:42PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
May 5, 2026 04:39PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
May 5, 2026 04:37PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
May 5, 2026 04:37PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
May 5, 2026 04:37PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
May 4, 2026 05:01PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
May 4, 2026 05:00PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
May 4, 2026 04:59PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
May 4, 2026 04:59PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
May 1, 2026 10:29AM Form 13F-HR Atlas Venture Advisors, For: Mar 31
May 1, 2026 10:26AM Form 13F-NT Atlas Venture Associates For: Mar 31
May 1, 2026 10:25AM Form 13F-NT Atlas Venture Associates For: Mar 31
May 1, 2026 10:22AM Form 13F-NT Atlas Venture Fund VIII, For: Mar 31
Apr 28, 2026 04:44PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
Apr 28, 2026 04:44PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
Apr 28, 2026 04:43PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
Apr 28, 2026 04:43PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
Apr 27, 2026 04:50PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
Apr 27, 2026 04:49PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
Apr 27, 2026 04:49PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
Apr 27, 2026 04:48PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
Apr 27, 2026 08:00AM Infinimmune Appoints Anthony Slavin, Ph.D., as Senior Vice President of Portfolio Strategy
Apr 24, 2026 04:47PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
Apr 24, 2026 04:47PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
Apr 24, 2026 04:46PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
Apr 24, 2026 04:46PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
Apr 23, 2026 06:56PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
Apr 23, 2026 06:56PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
Apr 23, 2026 06:56PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
Apr 23, 2026 06:56PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
Apr 22, 2026 04:54PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
Apr 22, 2026 04:54PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
Apr 22, 2026 04:53PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
Apr 22, 2026 04:53PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
View More Recent Stories View Older Stories